Comparison

(S,R,S)-AHPC-Me hydrochloride European Partner

Item no. TMO-T13671-200mg
Manufacturer TargetMol
CASRN 1948273-03-7
Amount 200 mg
Quantity options 100 mg 10 mg 1 g 200 mg 25 mg 2 g 500 mg 50 mg
Category
Type Chemicals
Specific against other
Formula C23H33ClN4O3S
Smiles Cl.C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](N)C(C)(C)C)c1ccc(cc1)-c1scnc1C
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias VHL ligand 2 hydrochloride,E3 ligase Ligand 1
Shipping Condition Cool pack
Available
Manufacturer - Targets
Ligand for E3 Ligase
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
481.05
Description
(S, R, S)-AHPC-Me hydrochloride (VHL ligand 2 hydrochloride) is utilized in the synthesis of ARV-771, a potent BET protein degrader. It selectively degrades BET protein in castration-resistant cells with a DC50 <1 nM. Recognized as VHL ligand 2 hydrochloride, it serves as the VHL ligand from (S, R, S)-AHPC for recruiting von Hippel-Lindau (VHL) protein.
Pathways
PROTAC
Bioactivity
(S, R, S)-AHPC-Me hydrochloride can be used to synthesize ARV-771, a von Hippel-Landau (VHL) E3 ligase-based BET PROTAC degrader. ARV-771 potently degrades BET protein in castration-resistant prostate cancer (CRPC) cells with a DC50 <1 nM. (S, R, S)-AHPC-Me h

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close